About
Portfolio
News
Contact
Contact us
Join Us
News
News
2023.01.24
Wugen Presents Data Supporting Clinical Development of WU-NK-101 for Relapsed / Refracto...
2023.01.24
Wugen Presents Data Supporting Clinical Development of WU-NK-101 for Relapsed / Refracto...
view more
2023.01.10
Neurelis announces filing of its investigational new drug application for nrl-1049, a rho kinase (r...
2023.01.10
Neurelis announces filing of its investigational new drug application for nrl-1049, a rho kinase (r...
view more
2022.12.13
Wugen Presents Data Supporting Clinical Development of WU-NK-101 for Relapsed / Refracto...
2022.12.13
Wugen Presents Data Supporting Clinical Development of WU-NK-101 for Relapsed / Refracto...
view more
2022.12.13
Onchilles Pharma Nominates First Drug Development Candidate Targeting Neutrophil Biology f...
2022.12.13
Onchilles Pharma Nominates First Drug Development Candidate Targeting Neutrophil Biology f...
view more
2022.11.08
Wugen to Present Data Characterizing WU-NK-101 at The Society for Immunotherapy of Cance...
2022.11.08
Wugen to Present Data Characterizing WU-NK-101 at The Society for Immunotherapy of Cance...
view more
2022.10.14
Neurelis Presents Novel, Investigational Analysis Of Valtoco® (Diazepam Nasal Spray) Civ...
2022.10.14
Neurelis Presents Novel, Investigational Analysis Of Valtoco® (Diazepam Nasal Spray) Civ...
view more
1
2
3
4
5
6
7
8
9
10
11